A study was conducted to evaluate the excretion pattern of melamine from feed into eggs, plasma, kidney, liver and muscle of laying hens. In particular, 90 laying hens were randomly allocated to three dietary treatments and fed diets contaminated with melamine at a level of 2.5, 25 and 250 mg of melamine/kg of diet for T1, T2 and T3 groups, respectively. The diets were offered in six replicate boxes (five hens each) for 13 days. Eggs were collected from each group for melamine quantification on days 0, 1, 3, 6, 9 and 13. At the end of the experimental period, one hen per box was randomly selected and slaughtered to collect plasma, liver, kidney and muscle samples. During the experiment, feeding diets with increasing levels of melamine had no effect (P . 0.05) on weight gain, feed intake, egg production, egg weight and mortality of laying hens. The melamine in eggs increased from day 1 after melamine ingestion and reached a plateau between days 6 and 13 of melamine ingestion. At steady-state condition, the melamine egg concentrations increased (P , 0.01) with treatments, being 0.026, 0.352 and 4.631 mg/kg for T1, T2 and T3, respectively. Similarly, the carryover of melamine from feed to egg increased (P , 0.05) with the levels of melamine in the diets, varying from 0.50 to 0.70 and 0.84 for T1, T2 and T3, respectively. The melamine was detected in plasma of all tested groups, increasing (P , 0.01) with levels of melamine in the diets (0.030, 0.266 and 4.102 mg/l in T1, T2 and T3, respectively). Melamine was not detected in kidney, liver and muscle of hens fed T1. Except for kidney sampled in the T3, no melamine concentration higher than 2.5 mg/kg, representing the maximum allowable limit set by the US Food and Drug Administration and European Union for food and feeds, was measured. The melamine resulted higher in plasma and kidneys than in the liver and muscle both in T2 and T3. The results confirmed the presence of an excretion pattern of melamine from feed to eggs and tissues in laying hens.
Introduction
Melamine (1,3,5-triazine-2,4,6-triamine) is a stable substance largely used in resin and plastic manufacture, including melaware. Melamine is also a minor metabolite of pesticide cyromazine, approved for use in many countries. Owing to its widespread distribution in food packaging, industrial products and links with pesticides and fertilizers, the US Food and Drug Administration (FDA) included melamine in the 'list of indirect additives used in food contact substances' (code number 000108-78-1). However, migration from food contact materials is low because melamine is hydrolyzed only in strong alkaline or acidic solutions. Recently, the European Food Safety Authority (EFSA, 2010) estimated that the average typical migration (trial with hot foodstuffs using typical contact conditions of time and temperature) are 1.0, 0.6, 0.2 and 0.05 mg melamine/kg acidic, aqueous, fatty and dry food, respectively. Consequently, a very high level of melamine in food and feeds is seen mainly as a deliberate adulteration to increase -E-mail: maurizio.moschini@unicatt.it nitrogen content. Effectively, melamine is a high source of nitrogen, containing 66.7% nitrogen by weight, higher than urea (46.6%) and biuret (40.8%). For this reason, some experiments were conducted to verify whether melamine could be used in ruminant nutrition as nonprotein nitrogen (Newton and Utley, 1978) ; however, the authors concluded that melamine was poorly hydrolyzed by rumen microorganisms and its use for this specific purpose was not suggested. Moreover, a high amount of melamine (i.e. 90%) was excreted within 24 h after the administration of a single oral dose in rats, confirming that melamine was poorly metabolized (Mast et al., 1983) .
More recently, melamine has been banned as feed or food additive because of its toxic and carcinogenic effects on the renal system. Melamine forms crystals in renal tubular and kidney tissues, and the contemporary presence of cyanuric acid in the diet increases the dimension and consistency of the crystals (Dobson et al., 2008) . The FDA (2007) reported cases of renal diseases in dogs and cats fed melamine-contaminated pet food, with the deaths of some subjects. One year later, the Chinese authority reported ,54 000 cases of kidney stones in infants, including four deaths related to the consumption of melamine-contaminated powdered infant formula (World Health Organization (WHO), 2008; Lam et al., 2009) . The WHO (2008) reported that melamine was deliberately added to raw milk to boost the nitrogen content. Further, the FDA and EFSA authorities updated the maximum melamine tolerable daily intake to levels of 0.63 and 0.50 mg/kg body weight (BW), respectively (EFSA, 2008; FDA, 2008) .
Some authors have recently suggested that melamine contamination in milk could be not only related to direct adulteration but also to the presence of melamine in feeds for lactating dairy cows, because of the fact that a passage of melamine from feed to milk and milk products was reported (Cruywagen et al., 2009; Battaglia et al., 2010; Shen et al., 2010; Sun et al., 2011; Zheng et al., 2011) . In addition, a carryover of melamine from feed to egg and body tissues of laying hens has been reported by different authors (Bai et al., 2010; Chen et al., 2010; Dong et al., 2010; Valat et al., 2011; Yang et al., 2011) . Recently, a pathway of melamine accumulation in various tissues (i.e. muscle, kidney, liver and abdominal fat) was reported in sheep, with a reported efficiency of melamine deposition in meat equal to ,3.5% (Cruywagen et al., 2011) .
Taking into account the maximum permitted level of melamine in feed and food (2.5 mg/kg) set by the FDA and the European Union, the objective of this study was to evaluate the excretion pattern of melamine in eggs produced by laying hens exposed to a wide range of melamine concentration in the diet. In particular, the animals were fed three different levels: equal to the permitted limit and 10-and 100-fold higher. The melamine concentration in plasma, kidney, liver and muscle were also evaluated.
Material and methods
Animal housing, diets and sampling A total of 90 laying hens (Isa Brown), aged 20 weeks, were randomly allocated to 18 groups (5 hens/group) and then associated with three dietary treatments (T1, T2 and T3; six groups for each treatments). The animals were housed in boxes (100 3 100 3 100 cm in width, length and height), equipped with a free-access feeding and water cups, in a light-and temperature-controlled house. The experiment was conducted at the CeRZOO (Research and Experimental Centre, San Bonico, Piacenza, Italy) in accordance with the Italian regulation legislative decree 116/92 and the study was approved by the Veterinary local service. The room temperature was set at 24.58C and the relative humidity at 55%; the illumination cycle was 16 h light : 8 h dark. Before the experimental period, all the hens were fed the same melamine-free basal diet (Table 1) for 14 adaptation days.
After the adaptation period, each group was fed one of the three melamine-contaminated diets. In particular, pure melamine (99%; Sigma-Aldrich, St Louis, MO, USA) was added to the basal diet and mixed for 3 min in a 150 kg experimental mixer to obtain melamine concentrations in the diets of 2.5, 25 and 250 mg/kg for T1, T2 and T3 groups, respectively. The experimental period lasted 13 days, during which each box was given (mean 6 s.d.) 10.1 6 0.6 kg of 2000) , methionine, lysine and melamine contents. The amino acids were quantified chromatographically (Jasco PU-2089; Jasco International Co., Hachigi, Tokyo, Japan) after a 24 h hydrolysis in HCl (Moore et al., 1958) .
The BW was measured on days 1 and 13 of the experimental period. The daily feed intake and egg production were measured on days 0, 1, 3, 6, 9 and 13 for each group. Eggs were collected on days 0, 1, 3, 6, 9 and 13, weighed, grouped per box and stored at 48C before being analyzed for melamine content. At the end of the experimental period, one hen from each box was randomly selected and slaughtered to collect blood (5 ml), kidney (whole), liver (whole) and breast muscles (50 g). Blood was transferred to Li-heparinized (17 U of heparin/ml of blood) test tubes (B.D. Vacutainer System; Becton, Dickinson and Co., Plymouth, UK) and immediately centrifuged (15 min at 48C for 3500 3 g) to obtain plasma. All tissue samples were kept at 2208C until the time of analysis.
Preparation of standard solution Melamine was purchased from Sigma-Aldrich. A stock melamine standard solution (400 mg/l) was prepared by dissolving 20 mg of melamine into 50 ml of a 2% aqueous formic acid : methanol (50 1 50 v/v) solution. Working standard solutions (from 0.2 to 10 mg/l) were prepared by further dilutions with 25 mM ammonium formate (pH 3.2) : methanol (10 1 90 v/v, HPLC mobile phase). Aliquots of these standards were diluted with a purified extract of melamine-free egg, as well as plasma, kidney, liver and muscle, to obtain solutions for calibration curve at a concentration of melamine ranging from 0.005 to 2.0 mg/l. Analysis of melamine Feeds. To extract melamine from the experimental diets, 10 g of ground feed was mixed with 100 ml 0.2 M HCl : methanol (75 1 25 v/v) using a rotary-shaking stirrer for 45 min. After filtration through a folded filter paper, 5 ml of the filtrate was mixed with 5 ml dichloromethane and centrifuged at 4500 3 g for 5 min. Further, 2 ml of the upper layer was purified through an Oasis MCX cartridge (6 cc 500 mg; Waters Corporation, Milford, MA, USA), previously conditioned with 5% NH 4 OH in methanol and 1% HCl in methanol (3 ml of each) and equilibrated with methanol and distilled water (3 ml of each). After washing the column with distilled water and methanol (3 ml of each), melamine was slowly eluted (0.5 ml/min) with 5% NH 4 OH in methanol (4 ml) into a graduated glass vial; subsequently, the eluate was concentrated to 2 ml under a gentle stream of nitrogen.
Eggs. For each box, three eggs were crushed (eggshells were removed and weighed) in a 50 ml polyethylene tube, and the content was homogenized using Ultra Turrax homogeneizer (Janke and Kunkel, IKA Labortechnik, Staufen, Germany) for 2 min at 9000 3 g. Subsequently, an aliquot of 10 ml homogenized eggs was diluted with 10 ml 0.4 M HClO 4 and centrifuged (11 000 3 g for 10 min at 48C). A volume of 5 ml of the supernatant solution was transferred to a glass vial, mixed with 5 ml dichloromethane and purified through an Oasis MCX cartridge as described for feed.
Plasma, kidney, liver and muscle. The melamine extraction and purification from plasma (2 ml) was carried out as described for eggs, whereas the extraction from kidney (2 g), liver (2 g) and breast muscles (5 g) was carried out as described above for feed analysis.
HPLC-mass spectrometry/mass spectrometry (MS/MS) analysis Analysis was carried out using a liquid chromatography (LC)-MS/MS system, consisting of a LC 1.4 Surveyor pump (Thermo-Fisher Scientific, San Jose, CA, USA), a PAL 1.3.1 sampling system (CTC Analytics AG, Zwingen, Switzerland) and a Quantum Discovery Max triple-quadrupole mass spectrometer; the system was controlled by an Excalibur 1.4 software (Thermo-Fisher Scientific). Melamine was separated on a Luna HILIC column (3 mm particle size, 150 3 2.0 mm; Phenomenex, Torrance, CA, USA) with mobile phase 25 mM ammonium formate (pH 3.2) : methanol (10 1 90 v/v); the flow rate was 0.15 ml/min. Ionization was carried out with an ESI interface (Thermo-Fisher Scientific) in positive mode as follows: spray capillary voltage 4.0 kV, sheath and auxiliary gas 8 and 1 psi, respectively, and temperature of the heated capillary 2708C. The mass spectrometric analysis was operated in selected reaction monitoring. For fragmentation of [M 1 H] 1 ion 127 m/z, the argon collision pressure was set to 1.3 mTorr; the selected fragment ions were 85 and 68 m/z with collision energy of 19 and 32 V, respectively. Before analysis, the purified extract of the sample was diluted (0.200 1 0.400 ml) with the mobile phase. The calibrant standards were diluted with the melamine-free extracts as for the samples. Quantitative determination was carried out using LC-Quan 2.0 software (Thermo-Fisher Scientific).
Carryover calculation
The carryover of melamine from feed to eggs was calculated on a 24 h basis by box at steady-state condition (Littell et al., 1998) as follows:
Carryover ð%Þ ¼ ðmelamine in eggs ðmg=kgÞ Â total egg weight without eggshell ðkg=boxÞÞ= ðdaily feed intake ðkg=boxÞ Â melamine diet concentration ðmg=kgÞÞ Â 100:
Statistical analysis Data were tested for normality with the Shapiro-Wilk test and when indication of no normal data was significant, data were log-normal transformed before statistical analysis. Data measured one time, at the end of experimental period (i.e. level of melamine in plasma, kidney, liver and muscle), were analyzed as a completely randomized design using the GLM procedure of SAS (2003), according to the model described below:
where Y ij is the dependent variable on the jth box assigned to treatment i, m is the overall mean, a i is the fixed effect of melamine log dose (i 5 1 to 3) and e ij is the residual error. Data measured over time, both during the entire experimental period (i.e. BW, daily feed intake, egg production, egg weight, melamine ingestion) and at steady-state condition (from days 6 to 13; i.e. melamine egg concentration, carryover), were analyzed as repeated measurements in a completely randomized design using the MIXED procedure of SAS (2003), according to the model described below:
where Y ijk is the dependent variable at time k on the jth box assigned to treatment i; m is the overall mean; a i is the fixed effect of melamine log dose (i 5 1 to 3); b ij is the random effect for the box j assigned to treatment i; g k is the fixed effect of time; (a 3 g) ik is the interaction between melamine log dose and time; and e ijk is the residual error. The experimental unit was the box. Each variable was subjected to two covariance structures: compound symmetry and unstructured. Using the Akaike information criterion and the Schwarz Bayesian criterion, compound symmetry was the covariance structure that best fitted the model. The linear effect (Lowry, 1992) of melamine ingestion on a logarithmic scale was evaluated and significance was declared at P , 0.05.
Results and discussion
Performances of the method The recovery percentages were evaluated by spiking known blank samples at different levels for each matrix. The limits of detection and quantification were determined by the signal-to-noise approach, defined as those levels resulting in signal-to-noise ratios of 3 and 10, respectively. The analytical response and the chromatographic noise were both measured from the chromatogram of a blank sample extract to which an appropriate volume of standard solution had been added. The data are shown in Table 2 .
Melamine in feed and animal performances As previously reported, the European Union and FDA (EU, 2008; FDA, 2008) fixed the maximum allowable limit of melamine in food and feeds at a level of 2.5 mg/kg in order to ensure a low risk for humans. The lowest level of melamine in the diet (T1) was chosen in agreement with this limit and had a melamine diet concentration of 2.39 6 0.05 mg/kg. Other tested diets showed a concentration ,10-to 100-fold higher than T1, the levels of melamine being equal to 24.76 6 0.29 and 256.37 6 4.92 mg/kg in T2 and T3, respectively. Bai et al. (2010) fed hens with melamine diet concentrations from 125 to 2000 mg/kg of feed (i.e. approximately from 8.6 to 140.9 mg/kg BW, respectively). Chen et al. (2010) and Dong et al. (2010) conducted experiments with laying hens exposed to low diet melamine contamination, from 0 to 100 mg of melamine/kg of diet. A wide range of melamine diet concentrations, ranging from 0 to 1000 mg/kg were tested by Lü et al. (2009) to evaluate the tissue residual melamine of broilers. Recently, Yang et al. (2011) used similar melamine concentrations by feeding laying hens with 200 or 1000 mg of melamine/kg of diet, whereas Valat et al. (2011) exposed animals to two melamine-contaminated diets with 50 and 500 mg of melamine/kg of diet, respectively. In our condition, no illness and death cases were recorded during the experimental period. Moreover, the ingestion of melamine-contaminated diets did not affect the BW, daily feed intake, egg weight and production (P . 0.05; Table 3 ). Lü et al. (2009) observed that feeding diet with a melamine concentration of 1 g/kg did not influence either broiler growing performance or feeding behavior. Similarly, Valat et al. (2011) did not observe differences in feed consumption and egg production among control and melamine-treated groups. As discussed by these authors, different reasons could be addressed for no effect on feeding behavior, yield performance and health status in hens following melamine ingestion. First, the doses tested in our work could be considered low when compared with documented cases of illness due to melamine (WHO, 2008) . Second, the melamine used in this experiment was the pure form and reasonably different from what produced industrially. Lastly, even if it was considered that the absence of cyanuric acid does not minimize the toxic effect of melamine (Battaglia et al., 2010) , it can be assumed that the concomitant assumption of these two compounds could facilitate the formation of nephrotoxic crystals (Dobson et al., 2008) .
Melamine in eggs Different authors reported an indirect melamine contamination of animal products, such as milk, cheese, meat and eggs, when animals were exposed to melamine-contaminated diets (Cruywagen et al., 2009; Dong et al., 2010; Cruywagen et al., 2011; Sun et al., 2011) . The existence of an excretion pattern from feed to eggs was also reported (Bai et al., 2010; Chen et al., 2010; Dong et al., 2010; Valat et al., 2011; Yang et al., 2011) . Our results confirmed that melamine could be found in eggs from hens ingesting melamine-contaminated diets, also at a low-level of melamine concentration (i.e. 2.39 6 0.05 mg/kg). The excretion pattern of melamine in eggs is shown in Figure 1 . No melamine was detected in eggs of each group the day before melamine-contaminated diet administration. The melamine egg concentrations (data corrected for the recoveries percentages) increased rapidly, with melamine being detected in eggs produced on day 1 in all groups. Other authors suggested that melamine was rapidly distributed to egg (Chen et al., 2010; Dong et al., 2010; Valat et al., 2011; Yang et al., 2011) . On the contrary, Bai et al. (2010) did not detect melamine on the first day of melamine ingestion, reporting that melamine egg concentration peaked on day 2 when hens were fed diet from 8.6 to 140.9 mg of melamine/kg of BW. After the first appearance, the melamine reached a steadystate condition from days 6 to 13 of the experimental period. Similar findings were observed referring to the graph data reported by Dong et al. (2010) , from which a day effect of melamine excretion pattern could be observed. Valat et al. (2011) reported that the melamine egg concentration reached a steadystate condition earlier, after 3 days of melamine ingestion, and then remained stable up to end of the experiment. On the contrary, Chen et al. (2010) did not report a day effect on melamine excretion pattern, suggesting that there is no accumulation for a later deposition in eggs. However, referring to tabular data reported by Chen et al. (2010) , a similar melamine egg excretion pattern could be observed. A different trend in melamine excretion pattern was reported by Yang et al. (2011) . The authors observed that the melamine in egg tended to increase from day 1 to days 18 and 19 for groups fed 200 and 1000 mg of melamine/kg of diet, respectively. Further, the melamine content of eggs decreased until the end of the melamine exposition period (day 28) by 31% and 13% (calculated on maximum melamine egg concentration) in the two groups, respectively. The concentration of melamine at steady-state condition increased linearly (P , 0.01) with log dose (Table 3) . However, only the value observed in T3 exceeded the allowed limit of melamine in food and feeds. The three levels of melamine (log dose) allow for a treatment evaluation up to a quadratic component. However, it was not considered as the number of tested treatments could lead to an expected quadratic effect. Chen et al. (2010) , by feeding hens at five different levels (from 0 to 100 mg/kg) for 15 days, reported that none of the tested diets caused a melamine egg concentration over the allowed limit. Moreover, the authors suggested that the melamine content of egg linearly increased with melamine diet concentration and proposed an equation to estimate egg melamine concentration starting from the diet contamination level. The proposed equation is:
Egg melamine concentration ðmg=kgÞ ¼ 0:08491þ 0:01473 Â diet contamination level ðmg=kgÞ:
As shown in Figure 2 , by applying the Chen et al. (2010) equation to predict melamine egg concentration (mg/kg) from tested diet contamination levels, slight overestimation and underestimation (ranging from 122.4% to 222.9% for T1 and T3, respectively) were observed when compared with values higher and lower than ,50 mg of melamine/kg of diet. Despite the different experimental conditions, the equation proposed by Chen et al. (2010) could be considered to correctly predict melamine egg concentration starting from the melamine level in the diet.
A similar approach was used to compare data of melamine egg concentrations measured by Dong et al. (2010) on day 17. Taking into account that the authors reported only the maximum level of melamine in eggs, a constant overestimation (,35%) was observed. This suggested that the melamine excretion pattern varied among experiments and this could be because of the specific experimental conditions in which they were conducted (species, age of animals, diet composition, group composition, environmental factors, etc.).
Considering the number of eggs collected for each box, the average egg weight without the eggshell (57.9, 58.3 and 57.8 g for T1, T2 and T3; respectively) and the feed ingestion at the observed steady-state condition, it was possible to calculate the carryover of melamine from feed into egg for each box (Table 3 ). The log dose linearly (P , 0.05) increased the carryovers of melamine with values of 0.50, 0.70 and 0.84 for T1, T2 and T3 groups, respectively. Higher carryover values (from 1.21% to 1.41%) were reported by Dong et al. (2010) . The different carryover rates could be related to the different approaches used: in the present work, the carryover was evaluated at steady-state condition, whereas Dong et al. (2010) measured the carryover on day 17, when the highest level of melamine in eggs occurred.
Melamine in plasma, muscle, liver and kidney The concentrations of melamine in plasma, muscle and organs are shown in Table 4 . The melamine was measured in plasma of all tested groups and increased with log dose, being 0.030, 0.266 and 4.102 mg/l, respectively, in T1, T2 and T3 (P , 0.05). No melamine was detected in kidney, liver and muscle samples from hens fed the T1 diet.
For T2, the values of plasma and kidney were similar and higher than those of muscle and liver. In T3, the plasma showed the highest melamine concentration (i.e. 4.102 mg/l). As reported in Table 3 , no samples of liver and breast muscles exceeded the maximum allowed limit of 2.5 mg/kg. It could be considered that the tissue concentration distributions of T2 follows the pattern: kidney . plasma . liver > muscle, and appeared similar to that reported by Bai et al. (2010) . On the contrary, Dong et al. (2010) reported lower levels in blood serum than in other tissues, whereas Valat et al. (2011) confirmed that the melamine content seemed to be higher in kidneys than in the liver and muscle. The tissue concentration distributions slightly differed for T3, that is, plasma . kidney . liver . muscle. This suggested that melamine absorption and metabolization could be affected by the amount of melamine ingested by animals, besides other factors, such as animals or species used in the experiment, health status and management of animals, length of melamine exposure period, source (i.e. pure or industrial) of melamine.
Lastly, our results showed that melamine concentration measured in eggs at steady-state condition could be considered similar to levels observed in plasma, being on average 0.026 v. 0. 030, 0.352 v. 0.266 and 4.631 v. 4 .102 mg/kg, respectively, for egg and plasma in T1, T2 and T3. Therefore, also supported by the observation reported by Dong et al. (2010) , the direct analysis of egg for melamine content could be useful to monitor melamine in laying hen, being a rapid way to obtain a good prediction of melamine exposure of animals and easier sampled than blood or other tissues.
Conclusions
A melamine excretion pattern from feed into egg and tissues was confirmed in laying hens, suggesting that the melamine contamination of these products should not only be related to intentional external contamination but also to the ingestion of melamine-contaminated diet. The rate of deposition in eggs was low and only the eggs from hens fed very high contaminated diet (i.e. 256 mg/kg of melamine) showed concentrations higher than 2.5 mg/kg, the upper limit currently allowed by the US FDA and the European Union in food. Thus, on the basis of our data, the risk for human health due to melamine-contaminated egg ingestion could be considered relevant only if the animals are given diets that are highly contaminated. In this study, the levels of melamine measured in plasma were similar or slightly lower than those in eggs. Table 2 ).
